China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.50+0.02 (+4.17%)
Close on Nov 17, 2026Market cap $21.51MP/E –Yield –
China Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
China Pharma's shares outstanding was 42M at Sep 30, 2026. For fiscal 2025 it was 4M, up 145.7% from the year before. Over ten years it grew 17.3% a year on average. The highest annual figure on record is 4M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4M | +145.7% |
| FY2024 | Dec 31, 2024 | 2M | -48.4% |
| FY2023 | Dec 31, 2023 | 3M | +221.8% |
| FY2022 | Dec 31, 2022 | 1M | +14.0% |
| FY2021 | Dec 31, 2021 | 1M | +5.7% |
| FY2020 | Dec 31, 2020 | 1M | +0.1% |
| FY2019 | Dec 31, 2019 | 1M | 0.0% |
| FY2018 | Dec 31, 2018 | 1M | 0.0% |
| FY2017 | Dec 31, 2017 | 1M | 0.0% |
| FY2016 | Dec 31, 2016 | 1M | 0.0% |
| FY2015 | Dec 31, 2015 | 1M | 0.0% |
| FY2014 | Dec 31, 2014 | 1M | 0.0% |
| FY2012 | Dec 31, 2012 | 1M | +0.2% |
| FY2011 | Dec 31, 2011 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 42M | +995.1% |
| Q2 FY2026 | Jun 30, 2026 | 41M | +1156.0% |
| Q1 FY2026 | Mar 31, 2026 | 26M | +684.9% |
| Q4 FY2025 | Dec 31, 2025 | 7M | +193.0% |
| Q3 FY2025 | Sep 30, 2025 | 4M | +123.8% |
| Q2 FY2025 | Jun 30, 2025 | 3M | +100.1% |
| Q1 FY2025 | Mar 31, 2025 | 3M | +144.7% |
| Q4 FY2024 | Dec 31, 2024 | 2M | -12.7% |
| Q3 FY2024 | Sep 30, 2024 | 2M | +2.4% |
| Q2 FY2024 | Jun 30, 2024 | 2M | -0.2% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +3.6% |
| Q3 FY2023 | Sep 30, 2023 | 3M | +164.2% |
| Q2 FY2023 | Jun 30, 2023 | 2M | +74.3% |
| Q1 FY2023 | Mar 31, 2023 | 2M | +70.6% |
| Q4 FY2022 | Dec 31, 2022 | 1M | +35.9% |
| Q3 FY2022 | Sep 30, 2022 | 1M | +8.8% |
| Q2 FY2022 | Jun 30, 2022 | 1M | +6.4% |
| Q1 FY2022 | Mar 31, 2022 | 1M | +3.9% |
| Q4 FY2021 | Dec 31, 2021 | 1M | +8.2% |
| Q3 FY2021 | Sep 30, 2021 | 1M | +5.6% |
| Q2 FY2021 | Jun 30, 2021 | 1M | +4.6% |
| Q1 FY2021 | Mar 31, 2021 | 1M | +4.6% |
| Q4 FY2020 | Dec 31, 2020 | 1M | +0.4% |
| Q3 FY2020 | Sep 30, 2020 | 1M | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | 1M | 0.0% |
| Q1 FY2020 | Mar 31, 2020 | 1M | 0.0% |
| Q4 FY2019 | Dec 31, 2019 | 1M | 0.0% |
| Q3 FY2019 | Sep 30, 2019 | 1M | 0.0% |
| Q2 FY2019 | Jun 30, 2019 | 1M | 0.0% |
| Q1 FY2019 | Mar 31, 2019 | 1M | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | 1M | 0.0% |
| Q3 FY2018 | Sep 30, 2018 | 1M | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | 1M | 0.0% |
| Q1 FY2018 | Mar 31, 2018 | 1M | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | 1M | 0.0% |
| Q3 FY2017 | Sep 30, 2017 | 1M | – |
| Q2 FY2017 | Jun 30, 2017 | 1M | – |
| Q1 FY2017 | Mar 31, 2017 | 1M | – |
| Q4 FY2016 | Dec 31, 2016 | 1M | – |
See a number that looks wrong?